NCT02086578View on ClinicalTrials.gov

Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients with Implant Reconstructions

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

March 11, 2014

Primary Completion Date

September 13, 2024

Study Completion Date

September 13, 2024

Conditions
Breast Cancer
Interventions
DEVICE

Breast MRI

BEHAVIORAL

Breast-Q© questionnaire

RADIATION

Multi-Beam IMRT

The radiation dose (50-50.4 Gy/25-28 fractions in approximately 5-6 weeks), treatment-planning and delivery aspects are according to departmental guidelines for breast IMRT.

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, East White Plains

11553

Memorial Sloan Kettering Nassau (Follow-Up only), Uniondale

11725

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack

07920

Memorial Sloan Kettering at Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

Unknown

Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02086578 - Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients with Implant Reconstructions | Biotech Hunter | Biotech Hunter